But for someone whos already lean and primarily interested in the weight-independent benefits of GLP-1 agonism cardiovascular protection, kidney protection, the emerging joint and metabolic signals that same metabolic acceleration works against you by burning through lean tissue youre trying to keep
However, the difference in weight loss outcomes between sites is typically modestthe dose strength and your personal metabolic response matter far more than whether you choose your abdomen or thigh
Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections
Review Telehealth FX, Henry Meds, Mochi Health, PlushCare, and local MedSpas for pricing, safety, and muscle protection
New data tie GLP-1 therapies to GERD by Jennifer Ford "These potential risks should be weighed against the established clinical benefits of this drug class." Its not the polyp, its the provider: Study by Julian Upton High-risk polyps are usually considered the main reason for shortened surveillance intervals
[DOI] [PubMed] [Google Scholar] 96.Ditzen B., Schaer M., Gabriel B., Bodenmann G., Ehlert U., Heinrichs M
